Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human SRPX2 ELISA Kit (AC2590)
Cat.#: ASET-1179
Specifications
Description Human SRPX2 ELISA Kit allows for the in vitro quantitative determination of human SRPX2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2209 Mouse TMPRSS2 ELISA Kit (AC3620) Quantitative inquiry ASET-2401 Human FGF2 ELISA Kit (AC3812) Quantitative inquiry ASET-1554 Human Neurofilament Heavy Polypeptide ELISA Kit (AC2965) Quantitative inquiry ASET-1838 Human LST1 ELISA Kit (AC3249) Quantitative inquiry ASET-1991 Human SLC25A12 ELISA Kit (AC3402) Quantitative inquiry ASET-1527 Mouse Neuropeptide Y ELISA Kit (AC2938) Quantitative inquiry ASET-1133 Human Neuroglobin ELISA Kit (AC2544) Quantitative inquiry ASET-1986 Rabbit Oxytocin ELISA Kit (AC3397) Quantitative inquiry ASET-1124 Human SOX3 ELISA Kit (AC2535) Quantitative inquiry ASET-2190 Human KIAA1199 ELISA Kit (AC3601) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket